Drug-Drug Interaction Between THC and AEF0117
Understand this study
Who could participate?
This study is for healthy volunteers. Listed age limits: 21 years to 55 years. Other eligibility criteria apply.
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- Aelis Farma
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- Not clearly listed
- Age range
- From 21 Years to 55 Years
- Official registry ID
- NCT06395688
- Official title
Show the full official title
A Double Blind, Placebo-controlled Trial in Healthy Volunteers to Investigate the Effect of Multiple Oral Doses of AEF0117 Versus Placebo on the Pharmacokinetics of THC and Its Metabolites 11 OH THC and THC COOH When Smoking Cannabis.
Recruitment & locations
Locations not listed
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Aelis Farma.
Does this study involve medication?
Yes. The study involves medication, including 3ß-(4-methoxybenzyloxy)pregn-5-en-20-one and Placebo.
Who can participate?
This study is for healthy volunteers. Listed age limits: 21 years to 55 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as withdrawn.
